Second-Quarter Outlook: 4 Big Pharma Companies Yielding An Average Of 4%
By Matt Schilling:Over the last year there have been many opportunities for investors within the pharmaceutical sector. That being said, growth and income investors should be pleased in the opportunity these four pharmaceutical companies offer investors not just in the second quarter, but for the long term as well. Bristol-Myers Squibb (BMY): Founded in 1887 and based in New York City, BMY currently trades at a P/E ratio of 15.05 and yields 4.1% ($1.36), making the stock very inexpensive when compared to other drugmakers. Analysts expect BMY to earn $0.50/share on revenue of $4.49 billion dollars for the second quarter and $1.96/share on revenue of $17.92 billion dollars for the year. BMY has beaten Street estimates three out of the last four quarters, and surpassed those three estimates by an average of 2.86%. Investors looking to establish a position should do so in a moderate fashion, acknowledging that not only are sharesComplete Story »
- Original article
- Login or register to post comments
